NORTHLAND

NORTHLAND

Language

NORTHLAND Wins the "Annual Best Performance Award" at the First Finance New Third Board Summit & Hua Xin Awards

发布时间：2014-12-15

On December 12, the First Finance New Third Board Summit and the "Hua Xin Award" Ceremony were successfully held at the Wanda Sofitel Hotel in Beijing. NORTHLAND was honored with the "Annual Best Performance Award." According to the organizers, NORTHLAND "has raised a substantial amount of capital in the capital market and enjoys high visibility. It has also demonstrated outstanding performance in corporate innovation. Highly praised by investment institutions, it is a star enterprise on the New Third Board."

05

2014-12

Northland was honored as one of the Top 50 Most Investment-Valuable Enterprises in China for 2014.

发布时间：2014-12-05

On December 4, 2014, the list of the "50 Most Investment-Valuable Companies in China—9th Edition," organized by Qichuang Group, was solemnly released. Beijing Northland Biotechnology Co., Ltd. was honored with the title of "50 Most Investment-Valuable Companies in China—9th Edition."

29

2014-08

Beijing Huonland Pharmaceutical Technology Co., Ltd. has successfully obtained a pharmaceutical production license.

发布时间：2014-08-29

On August 27, 2014, the newly built pharmaceutical plant of Beijing Huienland Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Huienland"), a controlling subsidiary of Beijing Northland Biotechnology Co., Ltd., obtained the "Drug Production License" issued by the Beijing Food and Drug Administration. The license is valid for five years. This marks that Huienland has basically met the requirements for drug production in terms of personnel, drug manufacturing, and drug quality management.

21

2014-07

The newly built pharmaceutical plant of Beijing Huonland Pharmaceutical Technology Co., Ltd. has been completed.

发布时间：2014-07-21

On July 18, 2014, the completion ceremony for the sterile eye-drop manufacturing facility of Beijing Huienland Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Huienland") was held in the Eastern Zone of the Tongzhou Economic-Technological Development Zone. The ceremony was attended by leading officials from the Tongzhou District Government, the Xiji Town Government, and the Management Committee of the Eastern Zone of the Economic-Technological Development Zone, as well as representatives from the Korean Embassy in China, relevant Chinese and foreign pharmaceutical companies, research institutes, and universities. Senior and mid-level management personnel from South Korea's HUONS Pharmaceutical Co., Ltd. and Beijing Northland Biotechnology Co., Ltd. also jointly witnessed this exciting historical moment.

14

2014-04

NORTHLAND is designated as the Beijing International Science and Technology Cooperation Base.

发布时间：2014-04-14

It is reported that, according to the announcement of the third batch of Beijing International Science and Technology Cooperation Base designations by the Beijing Municipal Science and Technology Commission, NORTHLAND has been designated as the “Beijing International Science and Technology Cooperation Base for Recombinant Innovative Drugs.”

22

2014-03

NORTHLAND Signs Strategic Cooperation Agreement with Pangen Co., Ltd. (Korea)

发布时间：2014-03-22

On March 22, 2014, Beijing Northland Biotechnology Co., Ltd. signed a strategic cooperation agreement with South Korea's Pangen Co., Ltd. in Beijing. Chairman Xu Songshan of NORTHLAND and Professor Jae Seung Yoon, Representative Director of Pangen, jointly attended the signing ceremony.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Friendly Links: Baidu | NORTHLAND

NORTHLAND

Contact Information

Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing

Hotline: +86 010-82890893

Email: northland@northland-bio.com

Website: www.northland-bio.com

Complaints Reporting Hotline: +86 010-82890893-8031

Complaints Reporting Email: pv@northland-bio.com

Follow Us

Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.

WeChat Mini Program

Web site

WeChat Official Account

NL-BIO

Scientific Research on Lower Limb Ischemia

NL003

Myocardial Infarction Scientific Research

NL005

Business license

Powered by 300.cn  Privacy Policy